ATA159597A - Präparat zur behandlung von blutgerinnungsstörungen - Google Patents

Präparat zur behandlung von blutgerinnungsstörungen

Info

Publication number
ATA159597A
ATA159597A AT0159597A AT159597A ATA159597A AT A159597 A ATA159597 A AT A159597A AT 0159597 A AT0159597 A AT 0159597A AT 159597 A AT159597 A AT 159597A AT A159597 A ATA159597 A AT A159597A
Authority
AT
Austria
Prior art keywords
preparation
blood coagulation
treating blood
coagulation disorders
disorders
Prior art date
Application number
AT0159597A
Other languages
English (en)
Inventor
Peter Dr Turecek
Hans-Peter Schwarz
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Priority to AT0159597A priority Critical patent/ATA159597A/de
Priority to PCT/AT1998/000228 priority patent/WO1999015197A1/de
Priority to AU92453/98A priority patent/AU9245398A/en
Publication of ATA159597A publication Critical patent/ATA159597A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT0159597A 1997-09-19 1997-09-19 Präparat zur behandlung von blutgerinnungsstörungen ATA159597A (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT0159597A ATA159597A (de) 1997-09-19 1997-09-19 Präparat zur behandlung von blutgerinnungsstörungen
PCT/AT1998/000228 WO1999015197A1 (de) 1997-09-19 1998-09-21 Präparat zur behandlung von blutgerinnungsstörungen
AU92453/98A AU9245398A (en) 1997-09-19 1998-09-21 Preparation for the therapy of disorders related to blood clotting

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0159597A ATA159597A (de) 1997-09-19 1997-09-19 Präparat zur behandlung von blutgerinnungsstörungen

Publications (1)

Publication Number Publication Date
ATA159597A true ATA159597A (de) 2000-09-15

Family

ID=3516826

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0159597A ATA159597A (de) 1997-09-19 1997-09-19 Präparat zur behandlung von blutgerinnungsstörungen

Country Status (3)

Country Link
AT (1) ATA159597A (de)
AU (1) AU9245398A (de)
WO (1) WO1999015197A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2926359T3 (es) * 2003-12-01 2022-10-25 Novo Nordisk Healthcare Ag Filtración de virus de composiciones líquidas del Factor VII
AT506216B1 (de) * 2008-02-13 2009-07-15 Peter Dr Hernuss Zusammensetzung zur aufnahme über mukoses gewebe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510248A (en) * 1993-06-22 1996-04-23 The University Of British Columbia Stable recombinant meizothrombin-like polypeptides
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
AT404597B (de) * 1995-11-24 1998-12-28 Immuno Ag Verfahren zur herstellung von proteinen
HUP9700603A3 (en) * 1996-03-20 2001-08-28 Baxter Ag Pharmaceutical preparation for the treatment of blood coagulation disorders
JP3976351B2 (ja) * 1997-04-08 2007-09-19 バクスター・アクチエンゲゼルシャフト 免疫寛容プロトロンビン複合体の調製

Also Published As

Publication number Publication date
WO1999015197A1 (de) 1999-04-01
AU9245398A (en) 1999-04-12

Similar Documents

Publication Publication Date Title
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
DE69939058D1 (de) Vorrichtung zur behandlung von peripheren gefässerkrankungen
DE69836640D1 (de) Vorrichtung zur behandlung von gewebe mit mehrfach-elektroden
DE69739303D1 (de) Vorrichtung zur thermischen behandlung von gewebe
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69829921D1 (de) Vorrichtung zur Behandlung von Körpergewebe
DE69827424D1 (de) Vorrichtung zur gesteuerten thermischen Behandlung von Gewebe
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE69924750D1 (de) Gerät zur thermischen behandlung von gewebe
DE69609868D1 (de) Neue steroidester zur behandlung von hauterkrankungen
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE69525473D1 (de) Vorrichtung zur behandlung von blutgefässen
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
DE69926385D1 (de) Behandlung von geweben
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
DE69710095D1 (de) Pharmazeutische zubereitung zur behandlung von diabetes
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
ATE296634T1 (de) (s,s)-reboxetin zur behandlung von fibromyalgie und anderen somatoformen störungen
DE69524682D1 (de) Mittel zur Behandlung von Wunden
DE59711321D1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
ATE247987T1 (de) Behandlung zur beseitigung von gerüchen
DE60028863D1 (de) Elektrochirurgisches Handstück zur Behandlung von Gewebe
DE69711311D1 (de) Vorrichtung zur thermischen Behandlung von Gewebe
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
A1J Withdrawal paragraph 166 lit. 6